In the absence of EBNA2 (the major viral transactivator protein in latency type III), the LMP promoters are activated by cellular proteins in nasopharyngeal carcinomas and in Sternberg-Reed cells of Hodgkin’s disease (latency type II), but not in type I BL cell lines or BL biopsies (type I latency) or memory B cells (type 0 latency, characterized by variable Qp activity)1. This evidence concerns the gene PDLIM7 and Hodgkins lymphoma.